Laboratory Tests for Hypoglycemia Evaluation
When evaluating suspected hypoglycemia, obtain a critical blood panel during an episode when plasma glucose is <60 mg/dL (3.3 mmol/L): plasma glucose, insulin, C-peptide, proinsulin, β-hydroxybutyrate, and screen for oral hypoglycemic agents 1.
Core Diagnostic Strategy
The evaluation hinges on capturing biochemical data during actual hypoglycemia, not at random times. The Endocrine Society guidelines provide the definitive framework 1:
Essential Labs During Hypoglycemia (glucose <60 mg/dL)
Primary panel:
- Plasma glucose (laboratory-measured, not point-of-care)
- Insulin (≥3 μU/mL indicates hyperinsulinism)
- C-peptide (≥0.6 ng/mL or 0.2 nmol/L indicates endogenous insulin)
- Proinsulin (≥5.0 pmol/L supports insulinoma)
- β-hydroxybutyrate (≤2.7 mmol/L confirms insulin-mediated suppression of ketogenesis)
- Oral hypoglycemic agent screen (sulfonylureas, meglitinides)
Additional tests:
- Insulin antibodies (can be measured later, not necessarily during hypoglycemia)
- Glucagon stimulation test: After documenting hypoglycemia, inject 1 mg IV glucagon and measure glucose at 10,20, and 30 minutes. A rise ≥25 mg/dL (1.4 mmol/L) indicates preserved glycogen stores and insulin excess 1, 2.
Clinical Context Determines Testing Approach
For Suspected Fasting Hypoglycemia
Perform a supervised 72-hour fast 1:
- Measure glucose, insulin, C-peptide, proinsulin, and β-hydroxybutyrate every 6 hours initially
- When glucose drops <60 mg/dL, increase sampling to every 1-2 hours
- End the fast when:
- Glucose <45 mg/dL (2.5 mmol/L) WITH symptoms/signs, OR
- Glucose <55 mg/dL (3.0 mmol/L) if Whipple's triad previously documented, OR
- 72 hours elapsed
Critical pitfall: Don't end the fast based solely on low glucose without symptoms—healthy women and children can have low fasting glucose 1.
At fast termination, obtain the complete panel above plus glucagon stimulation test 1.
For Suspected Postprandial Hypoglycemia
Perform a mixed-meal test (NOT oral glucose tolerance test) 1, 2:
- Use a meal similar to what triggers symptoms (or 50-60% carbohydrate mixed meal)
- Sample glucose, insulin, C-peptide, and proinsulin at baseline and every 30 minutes for 5 hours
- Only send insulin, C-peptide, and proinsulin for analysis when glucose <60 mg/dL 1
- If Whipple's triad occurs, add oral hypoglycemic screen and insulin antibodies 1
Important: An oral glucose tolerance test should never be used for hypoglycemia evaluation 1, 2.
Diagnostic Thresholds for Hyperinsulinemic Hypoglycemia
When glucose is <55 mg/dL (3.0 mmol/L), the following indicate endogenous hyperinsulinism 1, 2:
- Insulin ≥3 μU/mL (18 pmol/L)
- C-peptide ≥0.6 ng/mL (0.2 nmol/L or 200 pmol/L)
- Proinsulin ≥5.0 pmol/L
- β-hydroxybutyrate ≤2.7 mmol/L
- Glucose rise ≥25 mg/dL after glucagon
These values appear inappropriately elevated relative to the low glucose, not necessarily high in absolute terms 1.
Initial Screening Before Provocative Testing
Before subjecting patients to prolonged fasts or meal tests 1:
- Review medication list (insulin, sulfonylureas, alcohol, others)
- Assess for critical illness (sepsis, liver/renal failure)
- Check cortisol and ACTH if adrenal insufficiency suspected
- Examine for large tumors (non-islet cell tumors producing IGF-II)
If spontaneous hypoglycemia is captured with symptoms, obtain the critical panel immediately—this may obviate need for formal testing 2.
Key Distinctions in Lab Interpretation
Exogenous insulin: High insulin, low C-peptide (suppressed endogenous production)
Sulfonylurea/meglitinide: High insulin, high C-peptide, positive drug screen
Insulinoma: High insulin, high C-peptide, high proinsulin, negative drug screen, no antibodies
Insulin autoimmune syndrome: High insulin, variable C-peptide, positive insulin antibodies 1
Common Pitfalls to Avoid
- Don't rely on point-of-care glucose meters for diagnostic decisions—use laboratory plasma glucose 1
- Don't measure insulin/C-peptide when glucose >60 mg/dL—results are uninterpretable 1
- Don't use insulin:glucose ratios—they have no diagnostic utility 1
- Don't diagnose based on symptoms alone—Whipple's triad (symptoms + documented low glucose + relief with treatment) must be confirmed 2
The 2009 Endocrine Society guideline remains the authoritative framework, emphasizing that proper timing of sample collection during documented hypoglycemia is more important than the breadth of testing 1.